{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:32Z","timestamp":1791331232111,"version":"4.3.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.autrev.2026.104125","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:28:21Z","timestamp":1782404901000},"page":"104125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Kidney failure in patients with ANCA-associated vasculitis: A systematic review of outcomes"],"prefix":"10.1016","volume":"25","author":[{"given":"Andreas","family":"Kronbichler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ramirez de Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Cattin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnaby","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.autrev.2026.104125_bb0005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","article-title":"Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease","volume":"10","author":"Jennette","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104125_bb0010","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-113-9-656","article-title":"Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The glomerular Disease collaborative network","volume":"113","author":"Falk","year":"1990","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.autrev.2026.104125_bb0015","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/art.39562","article-title":"Diffuse alveolar Hemorrhage secondary to antineutrophil cytoplasmic antibody-associated Vasculitis: predictors of respiratory failure and clinical outcomes","volume":"68","author":"Cartin-Ceba","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104125_bb0020","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/rheumatology\/kew232","article-title":"Incidence of ANCA-associated vasculitis in a UK mixed ethnicity population","volume":"55","author":"Pearce","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2026.104125_bb0025","article-title":"ANCA associated vasculitis","volume":"369","author":"Hunter","year":"2020","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.autrev.2026.104125_bb0030","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.3390\/jcm11092573","article-title":"Systematic review and Metaanalysis of worldwide incidence and prevalence of antineutrophil cytoplasmic antibody (ANCA) associated Vasculitis","volume":"11","author":"Redondo-Rodriguez","year":"2022","journal-title":"J Clin Med"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2026.104125_bb0035","doi-asserted-by":"crossref","first-page":"i14","DOI":"10.1093\/ndt\/gfv022","article-title":"Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"30","author":"Watts","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.autrev.2026.104125_bb0040","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2026.104125_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000435","article-title":"Long-term patient survival in a Swedish population-based cohort of patients with ANCA-associated vasculitis","volume":"3","author":"Heijl","year":"2017","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.autrev.2026.104125_bb0050","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/ard.2007.071936","article-title":"Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European league against rheumatism systemic vasculitis task force","volume":"67","author":"Mukhtyar","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2026.104125_bb0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener\u2019s granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.autrev.2026.104125_bb0060","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.40313","article-title":"The epidemiology of antineutrophil cytoplasmic autoantibody-associated Vasculitis in Olmsted County, Minnesota: a twenty-year US population-based study","volume":"69","author":"Berti","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104125_bb0065","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.autrev.2026.104125_bb0070","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1046\/j.1523-1755.2003.00843.x","article-title":"Rapidly progressive crescentic glomerulonephritis","volume":"63","author":"Jennette","year":"2003","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.autrev.2026.104125_bb0075","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2215\/CJN.01020113","article-title":"Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis","volume":"8","author":"de Joode","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.autrev.2026.104125_bb0080","doi-asserted-by":"crossref","first-page":"e762","DOI":"10.1016\/S2665-9913(24)00187-5","article-title":"Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort","volume":"6","author":"Gisslander","year":"2024","journal-title":"Lancet Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104125_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102495","article-title":"Clinical associations of renal involvement in ANCA-associated vasculitis","volume":"19","author":"Kronbichler","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2026.104125_bb0090","doi-asserted-by":"crossref","first-page":"1244651","DOI":"10.3389\/fmed.2023.1244651","article-title":"Renal involvement in eosinophilic granulomatosis with polyangiitis","volume":"10","author":"Reggiani","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.autrev.2026.104125_bb0095","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","article-title":"Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study","volume":"41","author":"Booth","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.autrev.2026.104125_bb0100","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.semarthrit.2012.09.005","article-title":"Predictors for outcomes in patients with severe ANCA-associated glomerulonephritis who were dialysis-dependent at presentation: a study of 89 cases in a single Chinese center","volume":"42","author":"Li","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2026.104125_bb0105","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2215\/CJN.08290813","article-title":"Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure","volume":"9","author":"Lee","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.autrev.2026.104125_bb0110","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/art.39614","article-title":"Trends in long-term outcomes among patients with antineutrophil cytoplasmic antibody-associated Vasculitis with renal Disease","volume":"68","author":"Rhee","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104125_bb0115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.7326\/M19-1564","article-title":"Trends in antineutrophil cytoplasmic autoantibody-associated Vasculitis-related mortality in the United States, 1999 to 2017","volume":"172","author":"Steinberg","year":"2020","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.autrev.2026.104125_bb0120","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.kint.2020.02.010","article-title":"Nomenclature for kidney function and disease: report of a kidney disease: improving global outcomes (KDIGO) consensus conference","volume":"97","author":"Levey","year":"2020","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.autrev.2026.104125_bb0125","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/rheumatology\/kem146a","article-title":"BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis","volume":"46","author":"Lapraik","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.autrev.2026.104125_bb0130","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2026.104125_bb0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"3S","key":"10.1016\/j.autrev.2026.104125_bb0140","first-page":"S71","article-title":"KDIGO 2024 clinical practice guideline for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2026.104125_bb0145","doi-asserted-by":"crossref","unstructured":"Gualdi-Russo E, Zaccagni L. The Newcastle\u2013Ottawa scale for assessing the quality of studies in systematic reviews. Publications 2026; 14(1):4.","DOI":"10.3390\/publications14010004"},{"issue":"9","key":"10.1016\/j.autrev.2026.104125_bb0175","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/ndt\/gfae018","article-title":"Long-term outcome of kidney function in patients with ANCA-associated vasculitis","volume":"39","author":"Sanchez-Alamo","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.autrev.2026.104125_bb0165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1136\/ard-2023-224571","article-title":"Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated querying","volume":"83","author":"Gisslander","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2026.104125_bb0235","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ekir.2024.01.007","article-title":"Development of a kidney prognostic score in a Japanese cohort of patients with antineutrophil cytoplasmic autoantibody Vasculitis","volume":"9","author":"Takeda","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.autrev.2026.104125_bb0240","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X231188818","article-title":"A prognostic immune nutritional index can predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"15","author":"Ahn","year":"2023","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"12","key":"10.1016\/j.autrev.2026.104125_bb0245","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1093\/ckj\/sfad157","article-title":"Adding 6-month parameters for the prediction of kidney prognosis in ANCA-associated glomerulonephritis","volume":"16","author":"Boud\u2019hors","year":"2023","journal-title":"Clin Kidney J"},{"issue":"4","key":"10.1016\/j.autrev.2026.104125_bb0250","first-page":"893","article-title":"The predictive value of Berden\u2019s classification versus renal risk score for renal survival of Chinese patients with myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis","volume":"41","author":"Kong","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2026.104125_bb0255","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.ekir.2023.05.029","article-title":"Outcomes in ANCA-associated Vasculitis in Scotland: validation of the renal risk score in a complete National Cohort","volume":"8","author":"McGovern","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.autrev.2026.104125_bb0260","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2215\/CJN.06460622","article-title":"Maintenance of remission and risk of relapse in myeloperoxidase-positive ANCA-associated vasculitis with kidney involvement","volume":"18","author":"Casal Moura","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104125_bb0265","doi-asserted-by":"crossref","first-page":"2289614","DOI":"10.1080\/07853890.2023.2289614","article-title":"Impact of different ANCA serotypes on the long-term outcome of ANCA-associated vasculitis patients","volume":"55","author":"Qi","year":"2023","journal-title":"Ann Med"},{"issue":"5","key":"10.1016\/j.autrev.2026.104125_bb0155","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12519-023-00753-3","article-title":"Risk factors for renal outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis: a nationwide retrospective study in China","volume":"20","author":"Tan","year":"2024","journal-title":"World J Pediatr"},{"issue":"10","key":"10.1016\/j.autrev.2026.104125_bb0270","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.ekir.2023.07.008","article-title":"Changing phenotypes and clinical outcomes over time in microscopic polyangiitis","volume":"8","author":"Uzzo","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.autrev.2026.104125_bb0275","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-023-02755-4","article-title":"A modified renal risk score for Chinese patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"21","author":"Wang","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2026.104125_bb0170","article-title":"Secular trends of incidence, prevalence, and healthcare economic burden in ANCA-associated Vasculitis: An analysis of the 2002-2018 South Korea National Health Insurance Database","volume":"9","author":"Ahn","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"10.1016\/j.autrev.2026.104125_bb0280","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1016\/j.ekir.2022.09.011","article-title":"Relevance of combined clinicopathologic phenotype and antineutrophil cytoplasmic autoantibody serotype in the diagnosis of antineutrophil cytoplasmic autoantibody Vasculitis","volume":"7","author":"Alba","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.autrev.2026.104125_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.834878","article-title":"Assessment of renal risk score and histopathological classification for prediction of end-stage kidney Disease and factors associated with change in eGFR after ANCA-glomerulonephritis diagnosis","volume":"13","author":"Brilland","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104125_bb0160","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/ndt\/gfab250","article-title":"Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"37","author":"Casal Moura","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.autrev.2026.104125_bb0290","first-page":"793","article-title":"The survival nomograms for anti-neutrophil cytoplasmic antibody-associated glomerulonephritis patients with a follow-up of more than one year","volume":"40","author":"Chen","year":"2022","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104125_bb0295","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/annrheumdis-2022-222439","article-title":"The effect of achieving serological remission on subsequent risk of relapse, end-stage renal disease and mortality in ANCA-associated vasculitis: a target trial emulation study","volume":"81","author":"McDermott","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2026.104125_bb0300","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/ndt\/gfac240","article-title":"Association between kinetic of anti-neutrophil cytoplasmic antibody (ANCA), renal survival and relapse risk in ANCA glomerulonephritis","volume":"38","author":"Samoreau","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.autrev.2026.104125_bb0305","doi-asserted-by":"crossref","first-page":"80","DOI":"10.12688\/hrbopenres.13651.1","article-title":"ANCA-associated vasculitis in Ireland: a multi-Centre national cohort study","volume":"5","author":"Scott","year":"2022","journal-title":"HRB Open Res"},{"issue":"2","key":"10.1016\/j.autrev.2026.104125_bb0310","doi-asserted-by":"crossref","first-page":"39","DOI":"10.55563\/clinexprheumatol\/24ep0c","article-title":"Evaluating renal outcome of ANCA-associated renal vasculitis: comparative study of two histopathological scoring systems","volume":"39","author":"An","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104125_bb0315","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1681\/ASN.2020071074","article-title":"Reappraisal of renal arteritis in ANCA-associated vasculitis: clinical characteristics, pathology, and outcome","volume":"32","author":"Boudhabhay","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104125_bb0320","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.ekir.2021.08.002","article-title":"Clinical practice audit on the management of antineutrophil cytoplasmic antibody-associated vasculitis in the Netherlands","volume":"6","author":"Dirikgil","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1016\/j.autrev.2026.104125_bb0325","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/ckj\/sfaa169","article-title":"Increased incidence and improved prognosis of glomerulonephritis: a national 30-year study","volume":"14","author":"Heaf","year":"2020","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.autrev.2026.104125_bb0330","article-title":"Antineutrophil cytoplasmic antibody-associated Vasculitis with acute kidney injury: short-term recovery predicts long-term outcome","volume":"12","author":"Huang","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2026.104125_bb0335","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ekir.2020.12.037","article-title":"Incidence and temporal trend in risk factors of severe infections in ANCA-glomerulonephritis patients","volume":"6","author":"Jourdain","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1016\/j.autrev.2026.104125_bb0150","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.xkme.2021.04.005","article-title":"Application of the ANCA renal risk score in the United States: a single-Center experience","volume":"3","author":"Kant","year":"2021","journal-title":"Kidney Med"},{"issue":"18","key":"10.1016\/j.autrev.2026.104125_bb0340","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e120","article-title":"Male sex is a significant predictor of all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated Vasculitis","volume":"36","author":"Kwon","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"6","key":"10.1016\/j.autrev.2026.104125_bb0345","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/rheumatology\/keaa699","article-title":"Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study","volume":"60","author":"Rathmann","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2026.104125_bb0195","doi-asserted-by":"crossref","first-page":"13080","DOI":"10.1038\/s41598-021-92629-7","article-title":"A cohort study to investigate sex-specific differences in ANCA-associated glomerulonephritis outcomes","volume":"11","author":"Scott","year":"2021","journal-title":"Sci Rep"},{"issue":"29","key":"10.1016\/j.autrev.2026.104125_bb0350","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026733","article-title":"Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement: a comparative cohort study","volume":"100","author":"Speer","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.autrev.2026.104125_bb0190","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/ndt\/gfab158","article-title":"Lymphopaenia at diagnosis of anti-neutrophil cytoplasmic antibody-vasculitis with renal involvement is correlated with severity and renal prognosis","volume":"37","author":"Wacrenier","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.autrev.2026.104125_bb0355","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/s41598-021-81664-z","article-title":"Clinicopathological characteristics and outcomes of anti-neutrophil cytoplasmic autoantibody-related renal vasculitis with hyperuricemia: a retrospective case-control study","volume":"11","author":"Wang","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.autrev.2026.104125_bb0360","doi-asserted-by":"crossref","first-page":"731","DOI":"10.3904\/kjim.2020.039","article-title":"Clinical features of Korean elderly patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"36","author":"Yoo","year":"2021","journal-title":"Korean J Intern Med"},{"issue":"4","key":"10.1016\/j.autrev.2026.104125_bb0365","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40620-019-00695-y","article-title":"Tubulointerstitial damage and interstitial immune cell phenotypes are useful predictors for renal survival and relapse in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"33","author":"Bitton","year":"2020","journal-title":"J Nephrol"},{"issue":"11","key":"10.1016\/j.autrev.2026.104125_bb0370","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1681\/ASN.2019111197","article-title":"Efficacy of rituximab and plasma exchange in antineutrophil cytoplasmic antibody-associated Vasculitis with severe kidney Disease","volume":"31","author":"Casal Moura","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104125_bb0375","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00296-019-04406-5","article-title":"The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey","volume":"40","author":"Corral-Gudino","year":"2020","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.autrev.2026.104125_bb0380","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/annrheumdis-2019-216742","article-title":"Histopathological subgrouping versus renal risk score for the prediction of end-stage renal disease in ANCA-associated vasculitis","volume":"79","author":"Gercik","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2026.104125_bb0385","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2215\/CJN.14561119","article-title":"Developments in the histopathological classification of ANCA-associated glomerulonephritis","volume":"15","author":"van Daalen","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104125_bb0390","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/ckj\/sfaa073","article-title":"Long-term validation of the renal risk score for vasculitis in a southern European population","volume":"14","author":"Villacorta","year":"2020","journal-title":"Clin Kidney J"},{"issue":"9","key":"10.1016\/j.autrev.2026.104125_bb0395","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1093\/rheumatology\/kez589","article-title":"All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type","volume":"59","author":"Wallace","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.autrev.2026.104125_bb0400","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10157-020-01925-5","article-title":"ANCA-associated nephritis without crescent formation has atypical clinicopathological features: a multicenter retrospective study","volume":"24","author":"Zoshima","year":"2020","journal-title":"Clin Exp Nephrol"},{"issue":"12","key":"10.1016\/j.autrev.2026.104125_bb0405","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3349\/ymj.2019.60.12.1164","article-title":"Controlling nutritional status score is associated with all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated Vasculitis","volume":"60","author":"Ahn","year":"2019","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.autrev.2026.104125_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.607261","article-title":"Outcome predictors of biopsy-proven myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis","volume":"11","author":"Ge","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104125_bb0415","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/art.40776","article-title":"Effect of disease activity at three and six months after diagnosis on long-term outcomes in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"71","author":"Gopaluni","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104125_bb0420","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/rheumatology\/key319","article-title":"Clinical outcome in anti-neutrophil cytoplasmic antibody-associated vasculitis and gene variants of 11\u03b2-hydroxysteroid dehydrogenase type 1 and the glucocorticoid receptor","volume":"58","author":"Hessels","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.autrev.2026.104125_bb0180","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1007\/s10067-019-04458-9","article-title":"Distinction between MPO-ANCA and PR3-ANCA-associated glomerulonephritis in Chinese patients: a retrospective single-center study","volume":"38","author":"Hong","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2026.104125_bb0425","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/nep.13491","article-title":"Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-na\u00efve patients with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"24","author":"Kim","year":"2019","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"10.1016\/j.autrev.2026.104125_bb0225","first-page":"103","article-title":"Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome","volume":"58","author":"Wester Trejo","year":"2019"},{"issue":"3","key":"10.1016\/j.autrev.2026.104125_bb0185","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5152\/eurjrheum.2015.0043","article-title":"Updates in ANCA-associated vasculitis","volume":"3","author":"Pagnoux","year":"2016","journal-title":"Eur J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104125_bb0200","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1681\/ASN.0000000000000274","article-title":"The improved kidney risk score in ANCA-associated vasculitis for clinical practice and trials","volume":"35","author":"Bate","year":"2024","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.autrev.2026.104125_bb0205","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/ndt\/gfae035","article-title":"A predictive mortality score in ANCA-associated renal vasculitis","volume":"39","author":"Fage","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.autrev.2026.104125_bb0210","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ekir.2023.01.039","article-title":"Renal recovery for patients with ANCA-associated vasculitis and low eGFR in the ADVOCATE trial of Avacopan","volume":"8","author":"Cortazar","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.autrev.2026.104125_bb0215","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.ajkd.2019.04.031","article-title":"ANCA-associated Vasculitis: Core curriculum 2020","volume":"75","author":"Geetha","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.autrev.2026.104125_bb0220","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-143-9-200511010-00005","article-title":"Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis","volume":"143","author":"Hogan","year":"2005","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.autrev.2026.104125_bb0230","doi-asserted-by":"crossref","first-page":"S617","DOI":"10.1016\/j.ekir.2024.11.1098","article-title":"WCN25-1022 long-term kidney function beyond 12 months and kidney relapse after initiation of treatment for ANCA-associated vasculitis","volume":"2","author":"Uchida","year":"2025","journal-title":"Kidney Int Rep"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226001394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226001394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T03:04:58Z","timestamp":1786071898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226001394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":85,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1568997226001394"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104125","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney failure in patients with ANCA-associated vasculitis: A systematic review of outcomes","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104125"}}